These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 33015157

  • 21. The Diagnostic Value of Serum miRNA-221-3p, miRNA-382-5p, and miRNA-4271 in Ischemic Stroke.
    Wang Y, Ma Z, Kan P, Zhang B.
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1055-1060. PubMed ID: 28111007
    [Abstract] [Full Text] [Related]

  • 22. Circulating MicroRNA-4739 May Be a Potential Biomarker of Critical Limb Ischemia in Patients with Diabetes.
    Li JY, Cheng B, Wang XF, Wang ZJ, Zhang HM, Liu SF, Chen LS, Huang WJ, Liu J, Deng AP.
    Biomed Res Int; 2018 May; 2018():4232794. PubMed ID: 30539011
    [Abstract] [Full Text] [Related]

  • 23. The relation of aortic stiffness and in-stent restenosis in patients undergoing percutaneous coronary stenting.
    Mahfouz RA, Abdulmoneim A, Abduo M, Elawady W.
    Echocardiography; 2013 May; 30(5):582-7. PubMed ID: 23565733
    [Abstract] [Full Text] [Related]

  • 24. Plasma osteopontin concentration is elevated in patients with coronary bare metal stent restenosis.
    Yilmaz KC, Bal UA, Karacaglar E, Okyay K, Aydinalp A, Yildirir A, Muderrisoglu H.
    Acta Cardiol; 2018 Feb; 73(1):69-74. PubMed ID: 28841817
    [Abstract] [Full Text] [Related]

  • 25. Prognostic Value of Plasma Long Noncoding RNA ANRIL for In-Stent Restenosis.
    Wang F, Su X, Liu C, Wu M, Li B.
    Med Sci Monit; 2017 Oct 03; 23():4733-4739. PubMed ID: 28970468
    [Abstract] [Full Text] [Related]

  • 26. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
    Rathore S, Kinoshita Y, Terashima M, Katoh O, Matsuo H, Tanaka N, Kimura M, Tsuchikane E, Nasu K, Ehara M, Asakura K, Asakura Y, Suzuki T.
    EuroIntervention; 2010 Feb 03; 5(7):841-6. PubMed ID: 20142201
    [Abstract] [Full Text] [Related]

  • 27. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
    Wang X, Lu W, Wang X, Pan L, Fu W, Liu Q, Han Z, Sun G, Qin X, Li R, Zheng X, Shan Y, Qiu C.
    Int J Cardiovasc Imaging; 2020 Feb 03; 36(2):171-178. PubMed ID: 31919705
    [Abstract] [Full Text] [Related]

  • 28. Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography: A Novel Prothrombotic Marker of Coronary Artery Stent Restenosis.
    Bliden KP, Tantry US, Gesheff MG, Franzese CJ, Pandya S, Toth PP, Mathew DP, Chaudhary R, Gurbel PA.
    J Interv Cardiol; 2016 Apr 03; 29(2):168-78. PubMed ID: 26822493
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.
    Moldoveanu E, Mut-Vitcu B, Tanaseanu GR, Marta DS, Manea G, Kosaka T, Vidulescu C, Tanaseanu C.
    Clin Biochem; 2008 Dec 03; 41(18):1429-33. PubMed ID: 18930040
    [Abstract] [Full Text] [Related]

  • 31. Roles of MicroRNAs in Peripheral Artery In-Stent Restenosis after Endovascular Treatment.
    Wang M, Zhang W, Zhang L, Wang L, Li J, Shu C, Li X.
    Biomed Res Int; 2021 Dec 03; 2021():9935671. PubMed ID: 34368362
    [Abstract] [Full Text] [Related]

  • 32. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
    Lecchi C, Dalla Costa E, Lebelt D, Ferrante V, Canali E, Ceciliani F, Stucke D, Minero M.
    Animal; 2018 Feb 03; 12(2):366-375. PubMed ID: 28689512
    [Abstract] [Full Text] [Related]

  • 33. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT).
    Albiero R, Silber S, Di Mario C, Cernigliaro C, Battaglia S, Reimers B, Frasheri A, Klauss V, Auge JM, Rubartelli P, Morice MC, Cremonesi A, Schofer J, Bortone A, Colombo A, RESCUT Investigators.
    J Am Coll Cardiol; 2004 Mar 17; 43(6):943-9. PubMed ID: 15028348
    [Abstract] [Full Text] [Related]

  • 34. Circulating microRNAs in patients with intracranial aneurysms.
    Meeuwsen JAL, van T Hof FNG, van Rheenen W, Rinkel GJE, Veldink JH, Ruigrok YM.
    PLoS One; 2017 Mar 17; 12(5):e0176558. PubMed ID: 28459827
    [Abstract] [Full Text] [Related]

  • 35. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
    Kong J, Hou J, Ma L, Xing L, Jia H, Liu H, Zhang S, Yu B, Jang IK.
    Arch Cardiovasc Dis; 2013 Feb 17; 106(2):79-85. PubMed ID: 23527911
    [Abstract] [Full Text] [Related]

  • 36. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Weissman NJ, Turco MA, Ormiston JA, Stone GW.
    JACC Cardiovasc Interv; 2009 Dec 17; 2(12):1269-75. PubMed ID: 20129555
    [Abstract] [Full Text] [Related]

  • 37. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J, Liu Y, Cui RZ, Mao YM, Zhou J, Chen Q, Zhao FM, Yang GM.
    Chin Med J (Engl); 2013 Mar 17; 126(6):1019-25. PubMed ID: 23506572
    [Abstract] [Full Text] [Related]

  • 38. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S, Iwabuchi M, Inoue N, Nakamura S, Asano R, Nanto S, Hayashi Y, Shiode N, Saito S, Ikari Y, Kimura T, Hosokawa J, Nakamura M, Kotani J, Kozuma K, Mitsudo K.
    Am Heart J; 2013 Sep 17; 166(3):527-33. PubMed ID: 24016503
    [Abstract] [Full Text] [Related]

  • 39. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, García Del Blanco B, Seidelberger B, Iñiguez A, Gómez-Recio M, Masotti M, Velázquez MT, Sanchís J, García-Touchard A, Zueco J, Bethencourt A, Melgares R, Cequier A, Dominguez A, Mainar V, López-Mínguez JR, Moreu J, Martí V, Moreno R, Jiménez-Quevedo P, Gonzalo N, Fernández C, Macaya C, RIBS V Study Investigators, under the auspices of the Working Group on Interventional Cardiology of the Spanish Society of Cardiology.
    J Am Coll Cardiol; 2014 Apr 15; 63(14):1378-86. PubMed ID: 24412457
    [Abstract] [Full Text] [Related]

  • 40. Impact of plasma aldosterone levels for prediction of in-stent restenosis.
    Amano T, Matsubara T, Izawa H, Torigoe M, Yoshida T, Hamaguchi Y, Ishii H, Miura M, Hayashi Y, Ogawa Y, Murohara T.
    Am J Cardiol; 2006 Mar 15; 97(6):785-8. PubMed ID: 16516576
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.